BMY vs SGLY · P/E 17, rev $24.46B vs rev $1.8M
Bristol-Myers Squibb Company (BMY) versus Singularity Future Technology Ltd (SGLY) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Singularity Future Technology Ltd (SGLY) is a integrated freight & logistics company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported SGLY revenue for 2025-06-30 was $1.8M. Net income was -$3.9M. SGLY currently screens at market cap $2.8M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. SGLY currently screens at market cap $2.8M.
Not investment advice. Open the BMY and SGLY stock pages for the full models.
Not investment advice.